This federal contract award, with ID SPE2DB22D1002|SPE2DB25FKVQ4, is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical product. The contract, valued at $3,676.42, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is December 17, 2024.
The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 3/17/25, 9:56 AM